Evos
Evos builds AI operators that learn from experienced employees and carry out operational work inside existing business software.
$9MPre-seed
ParticipantCC
Crosslink Capital
Activity from announced rounds
Activity in this selectionAI
Crosslink Capital is an investment firm whose own portfolio news identifies Yardstik, RockRose Risk and Intermezzo.
Recorded funding activity
Yardstik combines fraud prevention, background screening and workforce monitoring. RockRose links wildfire mitigation with property insurance, while Intermezzo supplies international payroll APIs. The covered financings connect these distinct products to the same firm-level investor.
Sources
- Rounds participated in
- 9
- Confirmed lead rounds
- 1 6 roles undisclosed
- New companies
- 9 First participation on record · 0 follow-on
- Funding in participating rounds
- $202.1M 9 disclosed · full round size, not this investor’s share
By stage
1 more
Series C+1
By primary sector
By country
Rounds
9 in this selectionSuki
Suki develops AI software that helps clinicians document visits and healthcare technology vendors embed clinical assistance in their products.
$90MSeries E
ParticipantIntermezzo
Intermezzo gives payroll and HR platforms an API for calculating and running payroll across countries.
$10MFunding
Role not disclosedRockRose Risk
Offers wildfire mitigation and insurance for property owners through a single platform
$12.5MSeries A
Role not disclosedAbstract
Streaming security operations that detect threats in motion and route data across an organisation’s tools.
$25MUndisclosed
Role not disclosedApaluma
Apaluma connects government regulatory records in a searchable, location-aware data platform.
$5.6MSeed
LeadSOND
Builds closed-loop in-ear earbuds that capture physiological signals and deliver real-time AI-guided sleep interventions
$7MSeed
Role not disclosedQuadSci
Analyzes telemetry events to connect customer behavior to revenue outcomes
$8MSeries A
Role not disclosedCompa
Provides AI-driven compensation intelligence for enterprise teams
$35MSeries B
Role not disclosed